EUCALIA (286A.T) Stock Price

EUCALIA Price

CLOSED
761.00
​
Market closed

Over the last 3 years EUCALIA grew revenue by 14.2% annually, reaching 24.40 B JPY. Earnings per share have grown at 41.6% per year over the last 3 years. For EUCALIA, the net margin of 11.4% is up versus 6.0% a few years ago. The consensus 12-month price target for EUCALIA is 1,387.20 JPY, about 82.3% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.

EUCALIA stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EUCALIA business model & stock analysis

EUCALIA Inc is a JP-based company operating in industry. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 812 full-time employees. The company went IPO on 2024-12-12. EUCALIA Inc is a Japan-based company mainly engaged in healthcare-related businesses. The company operates through three segments. The Medical Management Comprehensive Support Business segment provides comprehensive support for issues faced by affiliated medical corporations, including management consulting, personnel recruitment support, digital transformation (DX) support, and fundraising support. The Senior Related Business segment provides nursing care services such as the operation of nursing care facilities, as well as consultation on admission to nursing care facilities and facility introduction services. The Highly Controlled Medical Device Business segment manufactures and sells contact lenses. The company also provides treatment progress data analysis and sales activity support services for pharmaceutical companies. Through its subsidiaries, it is also engaged in venture investment, as well as the provision of brain checkup services, and real estate buying and selling services.

Frequently asked questions about EUCALIA

Analysts currently set an average price target of 1,387.20 JPY for the EUCALIA stock (median: 1,387.20 JPY), implying +82.3 % versus the latest price. The consensus is based on 6 analyst ratings.

6 analysts currently rate the EUCALIA stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect EUCALIA to generate revenue of 31.79 B JPY and earnings per share of 43.27 JPY.

Converted at the current exchange rate, the EUCALIA share trades at 4.28 EUR (761.00 JPY).

The expected revenue of EUCALIA is 31.79 B JPY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of EUCALIA is 1.55 B JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of EUCALIA is currently 17.59. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the EUCALIA stock.

The price-to-sales ratio (P/S) of EUCALIA is currently 0.86. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the EUCALIA stock.

The Eulerpool Quality Score for EUCALIA is 4/10.

The ISIN of EUCALIA is JP3946900002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of EUCALIA is 286A.T. The ticker symbol is used to trade EUCALIA shares on the stock exchange.

Fair ValueTerminal
738.17 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue per Employee
30.05 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website eucalia.jp
Country
Currency
JPY
Initial public offering
Dec 12, 2024
ISIN
JP3946900002
Cusip
J1R80P106
Market capitalization
28.90 B JPYLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
18.70
P/Ee 2027
15.64
P/S
P/Se
0.86
EV/EBIT
15.35
P/B Ratio
1.41
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
7.50 %
Last updated Oct 21, 2026, 2:23 AM

EUCALIA Peer Group

All fundamentals and in-depth analysis of EUCALIA

Our stock analysis for EUCALIA stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of EUCALIA. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.